Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids
11 juin 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs’ (OTCQB: KBLB) BAM-1 spider silk hybrid strain continues to set records for silkworm size, growth, and robustness.
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
11 juin 2024 06h00 HE
|
NMD Pharma
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients Aarhus, Denmark, 11 June 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel...
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
11 juin 2024 01h00 HE
|
NMD Pharma
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients Aarhus, Denmark, 11 June 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing...
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia
06 juin 2024 21h13 HE
|
EnGeneIC
SYDNEY, Australia, June 06, 2024 (GLOBE NEWSWIRE) -- EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has...
Rapport Therapeutics Announces Pricing of Initial Public Offering
06 juin 2024 18h54 HE
|
Rapport Therapeutics, Inc.
BOSTON and SAN DIEGO, June 06, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...
BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit
06 juin 2024 10h00 HE
|
Bio North Texas
BioNTX, the leading biotechnology trade organization in North Texas, is thrilled to announce the 10th Annual iC³® Life Science Summit.
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
06 juin 2024 08h00 HE
|
Madrigal Pharmaceuticals, Inc.
Late-breaking AI-based analysis of MAESTRO-NASH biopsy data demonstrates Rezdiffra improved key fibrotic features that are predictive of progression to decompensated cirrhosisNoninvasive test data...
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
05 juin 2024 08h00 HE
|
Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Goldman Sachs 45th Annual Global...
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
05 juin 2024 07h00 HE
|
CytoSorbents
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
04 juin 2024 16h10 HE
|
Abivax
PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the...